血清α-L-岩藻糖苷酶(AFU)对原发性肝癌(PHC)的诊断意义  

Serum α-L-fucosidase for the diagnosis of primary hepatic carcinoma

作　　者：徐祖龙[1] 

机构地区：[1]江苏省泰州市人民医院检验科,225300

出　　处：《中国实用医药》2009年第35期25-26,共2页China Practical Medicine

摘　　要：目的研究血清α-L-岩藻糖苷酶(AFU)对原发性肝癌的诊断意义。方法分别测定20例正常对照者、45例慢性乙型肝炎、40例肝硬化、50例转移性肝癌及35例原发性肝癌患者的血清AFU。结果原发性肝癌组的血清AFU浓度和阳性率显著高于其他各组。结论血清AFU对原发性肝癌的诊断有重要价值。Objective To study the significance of serum α-L-fucosidase （AFU） in the diagnosis of primary hepatic carcinoma （PI-IC）. Methods The activities of serum AFU were measured in 20 healthy subjects.45 cases of Chronic Hepatitis B.40 cases of liver cirrhosis.50 cases of secondary hepatic carcinoma and 35 cases of PHC. Results The AFU activities in patients with PHC were significantly higher than those of any other groups. The positive rate in patients with PHC was 74. 28% that was higher than other groups. Conclusions The serum AFU is a useful marker for the diagnosis of PHC.

关 键 词：Α-L-岩藻糖苷酶 原发性肝癌 

分 类 号：R735.7[医药卫生—肿瘤]